The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of low expression of VEGF121 soluble isoform with prognostic impact and survival in patients with activated B-cell-like (ABC-like) diffuse large B-cell lymphoma (DLBCL) from the CORAL trial.
Catherine Thieblemont
No relevant relationships to disclose
Nicolas Mounier
No relevant relationships to disclose
Samia Mourah
No relevant relationships to disclose
Remi Houlgatte
No relevant relationships to disclose
Edouard Hirchaud
No relevant relationships to disclose
Wendy Cuccuini
No relevant relationships to disclose
Loic Ysebeart
No relevant relationships to disclose
Dominique Bron
No relevant relationships to disclose
Philippe Gaulard
No relevant relationships to disclose
Christian Gisselbrecht
No relevant relationships to disclose
Josette Briere
No relevant relationships to disclose